Arkansas Financial Group Inc. Acquires 472 Shares of iShares U.S. Pharmaceuticals ETF $IHE

Arkansas Financial Group Inc. boosted its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 7.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,185 shares of the company’s stock after acquiring an additional 472 shares during the quarter. Arkansas Financial Group Inc. owned approximately 0.09% of iShares U.S. Pharmaceuticals ETF worth $477,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. NBC Securities Inc. bought a new position in iShares U.S. Pharmaceuticals ETF during the first quarter valued at approximately $30,000. Arlington Trust Co LLC acquired a new position in iShares U.S. Pharmaceuticals ETF during the first quarter valued at approximately $32,000. Garde Capital Inc. acquired a new position in iShares U.S. Pharmaceuticals ETF during the first quarter valued at approximately $46,000. Wayfinding Financial LLC acquired a new position in iShares U.S. Pharmaceuticals ETF during the first quarter valued at approximately $47,000. Finally, IFP Advisors Inc grew its holdings in iShares U.S. Pharmaceuticals ETF by 231.2% during the first quarter. IFP Advisors Inc now owns 944 shares of the company’s stock valued at $67,000 after purchasing an additional 659 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Down 1.6%

Shares of IHE stock opened at $69.09 on Friday. iShares U.S. Pharmaceuticals ETF has a 12 month low of $58.97 and a 12 month high of $73.28. The business’s 50 day moving average is $69.41 and its two-hundred day moving average is $67.18. The company has a market cap of $566.54 million, a PE ratio of 17.75 and a beta of 0.70.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.